QLI Qilian International Holding Group Ltd

Qilian International Holding Group Limited is a pharmaceutical and chemical company based in China with over 50 years of operation. We focus on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers. We independently developed Gan Di Xin® and Ahan® Antibacterial Paste within our research and development department. Our products are sold in more than 20 provinces in China . Our licorice products include Gan Di Xin®, Qilian Shan® Licorice Extract, and Qilian Shan® Licorice Liquid Extract. Our Gan Di Xin® is an innovative antitussive and expectorant medicine made from raw licorice materials. Our Qilian Shan® Licorice Extract is a primary ingredient for pharmaceutical companies to manufacture traditional licorice tablets. Our Qilian Shan® Licorice Liquid Extract is the primary ingredient for medical preparation companies to produce compound licorice oral solutions.

$3.77
As of 10/25/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  China
Country of incorporation:  
IPO date:  07/14/2014
Outstanding shares:  35,750,000
Average volume:  17,907
Market cap:   $139,174,750
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   56.64
PB ratio:   2.58
PS ratio:   2.87
Return on equity:   11.02%
Net income %:   12.24%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy